| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/11/2000 | WO2000025764A2 Compositions for the treatment and prevention of cardiovascular diseases |
| 05/11/2000 | WO2000009110A3 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 05/11/2000 | WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 05/11/2000 | WO2000007565A3 Methods of ophthalmic administration |
| 05/11/2000 | WO1999060984A3 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| 05/11/2000 | DE19851282A1 Zusammensetzung einer pharmazeutisch wirksamen Substanz, appliziert in einem spezifischen Delivery-System zur Prävention und Behandlung von Infektions-Krankheiten Composition of a pharmaceutically active substance, applied in a specific delivery system for the prevention and treatment of infectious diseases |
| 05/11/2000 | CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 05/11/2000 | CA2349818A1 Membrane transport proteins |
| 05/11/2000 | CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 05/11/2000 | CA2349427A1 Method for preventing increased iridial pigmentation during prostaglandin treatment |
| 05/11/2000 | CA2348703A1 Inhibitors of prenyl-protein transferase |
| 05/11/2000 | CA2348446A1 Benzamide potassium channel inhibitors |
| 05/11/2000 | CA2348392A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | CA2345337A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/11/2000 | CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/10/2000 | EP0998931A1 Remedies for dry eye |
| 05/10/2000 | EP0998925A1 Medicinal compositions for topical administration containing vitamin d and vitamin k |
| 05/10/2000 | EP0998916A1 Medicinal compositions for application to mucosa |
| 05/10/2000 | EP0998277A1 Ophthalmic compositions for treating ocular hypertension |
| 05/10/2000 | EP0800503B1 Novel trienoic retinoid compounds and methods |
| 05/10/2000 | CN1252721A Pharmaceutical composition |
| 05/10/2000 | CN1252718A Remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells |
| 05/09/2000 | US6060508 Benzylamine derivatives, their preparation and their application in therapeutics |
| 05/09/2000 | US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 05/09/2000 | US6060479 Quinazoline-4-one AMPA antagonists |
| 05/09/2000 | US6060463 Treatment of conditions of abnormally increased intraocular pressure by administration of phosphonylmethoxyalkyl nucleoside analogs and related nucleoside analogs |
| 05/09/2000 | US6060460 Use of betaglycan to reduce scarring |
| 05/09/2000 | CA2151560C Insulin analog formulations |
| 05/09/2000 | CA2129679C Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
| 05/04/2000 | WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 05/04/2000 | WO2000024742A1 Pyrazolopyridine as adenosine antagonists |
| 05/04/2000 | WO2000024724A1 Thiazole-derivatives |
| 05/04/2000 | WO2000024707A1 Substituted phenyl derivatives, their preparation and use |
| 05/04/2000 | WO2000024415A2 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 05/04/2000 | WO2000024396A1 Treatment of disorders of the outer retina |
| 05/04/2000 | WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | WO2000024375A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 05/04/2000 | WO2000024359A2 Use of gndf for treating retinal degeneration |
| 05/04/2000 | WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases |
| 05/04/2000 | CA2348835A1 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 05/04/2000 | CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | CA2342626A1 Substituted phenyl derivatives, their preparation and use |
| 05/04/2000 | CA2340225A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 05/03/2000 | EP0996612A2 Aliphatic propargylamines as cellular rescue agents |
| 05/03/2000 | EP0996465A1 Compositions and articles for reducing the effects of inflammation |
| 05/03/2000 | EP0996456A1 Methods for treating neurological deficits |
| 05/03/2000 | EP0996446A1 Novel substituted imidazole compounds |
| 05/03/2000 | EP0719767B1 Succinamic acid compound, process for producing the same, and use thereof |
| 05/03/2000 | CN1252001A Method for destroying retinal pigment epithelial cells |
| 05/02/2000 | US6057445 Formation of carbon nitrogen bond, cyclization and halogenation |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp |
| 05/02/2000 | US6057349 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxphenyl, and aminophenyl alkylsulfonamides and ureas and their use |
| 05/02/2000 | US6057338 Useful in the treatment of diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome, pain and diabetic retinopathy |
| 05/02/2000 | US6057336 Lactam metalloprotease inhibitors |
| 05/02/2000 | US6057334 Benzo[g]quinoline derivatives |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023438A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000023048A1 Perfusate preparation for ophthalmic operation |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | DE19856210A1 Use of thiol compound selected from oxidoreductase and/or hydrolase for treatment of chronic and acute tinnitus |
| 04/27/2000 | CA2347921A1 Preparation of irrigating solution for ocular surgery |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2346436A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/26/2000 | EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995743A1 Derivatives of dihydro- and tetrahydrochinoline as a medicinal antioxydans |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994717A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 04/26/2000 | EP0994709A1 Calcium blockers to treat proliferative vitreoretinopathy |
| 04/26/2000 | EP0994705A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 04/26/2000 | EP0994693A2 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 04/26/2000 | EP0736020B1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 04/26/2000 | EP0670826B1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 04/26/2000 | EP0559700B1 Novel pilocarpine derivatives and process for their preparation |
| 04/26/2000 | CN1251531A Treatment of inner ear hair cells |
| 04/26/2000 | CN1251521A Compound and method for therapeutic intervention in preventing diabetic complications |
| 04/26/2000 | CN1251520A Use of sodium channel blocker in manfacture of medicament for preventing optic nerve degeneration associated with glaucoma |
| 04/25/2000 | US6054588 Heterocyclic vinyl ethers |
| 04/25/2000 | US6054485 Eye treatments using synthetic thyroid hormone compositions |
| 04/25/2000 | US6054457 Benzamide derivatives and their use as vasopressin antagonists |
| 04/25/2000 | US6054449 Photodynamic therapy |
| 04/25/2000 | US6054143 Xylitol delivery |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids |
| 04/23/2000 | CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000021978A2 Laminin 5, 13 and 14 and uses thereof |
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021955A1 Quinazoline derivatives |
| 04/20/2000 | WO2000021564A1 Composition and method for treating allergic diseases |